Opinions
Peter Brieger
Pharmagap
GAP-X
TRADE
Sep 29, 2004
A spinoff from the National Research Council. Speculative. Likes it but hasn't done well. Doesn't know where it's going.
$0.250
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.